Who Benefits from Immunotherapy in Lung Cancer? More Patients than Previously Thought, According to New Research

Updated June 21st, 2021

Who Benefits from Immunotherapy in Lung Cancer? More Patients than Previously Thought, According to New Research

A new analysis shows that, among patients with metastatic non-squamous non-small cell lung cancer, the benefits of immunotherapy hold true regardless of the presence of a KRAS mutation.

NOW
PLAYING
Theranos Trial Will Feature Misdiagnosed Cancer Patient
NOW
PLAYING
Friends Star James Michael Tyler Says Chemo Is Helping Cancer Battle
NOW
PLAYING
Colorectal Cancer Screenings Beneficial For Adults Over 75
NOW
PLAYING
Non-Smokers Take Note: Kathy Griffin is Part of the 20% of Lung Cancer Patients Who Have Never Smoked; What You Need to Know
NOW
PLAYING
Nightbirde Withdraws From 'AGT' Amid Breast Cancer Battle
NOW
PLAYING
Brave Siblings, 7 and 2, Fight Back After Childhood Cancer Diagnoses

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.